|Bid||1,880.25 x 900|
|Ask||1,883.03 x 1200|
|Day's range||1,873.32 - 1,874.85|
|52-week range||1,472.45 - 2,230.24|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||242.27|
|Forward dividend & yield||47.50 (2.35%)|
|Ex-dividend date||30 Dec 2021|
|1y target est||N/A|
General Electric's (GE) 10-year partnership deal with Circle Health will likely improve patient health outcomes across the latter's network of around 50 hospitals in the United Kingdom.
Danaher (DHR) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Danaher (DHR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.